DPI-221

From Wikipedia, the free encyclopedia
Jump to: navigation, search
DPI-221
DPI-221.svg
Systematic (IUPAC) name
4-((αS)-α-((2S,5R)-2,5-dimethyl-4-(3-fluorobenzyl)-1-piperazinyl)benzyl)-N,N-diethylbenzamide
Clinical data
Legal status
?
Identifiers
ATC code ?
PubChem CID 9891642
Chemical data
Formula C21H38FN3O 
Mol. mass 487.65 g/mol
 YesY (what is this?)  (verify)

DPI-221 is a opioid drug that is used in scientific research. It is a highly selective agonist for the δ-opioid receptor, which produces fewer convulsions than most drugs from this family.[1]

References[edit]

  1. ^ Holt, JD; Watson, MJ; Chang, JP; O'Neill, SJ; Wei, K; Pendergast, W; Gengo, PJ; Chang, KJ (2005). "DPI-221 4-((alpha-s)-alpha-((2s,5r)-2,5-dimethyl-4-(3-fluorobenzyl)-1-piperazinyl)benzyl)-N,N-diethylbenzamide: a novel nonpeptide delta receptor agonist producing increased micturition interval in normal rats". The Journal of Pharmacology and Experimental Therapeutics 315 (2): 601–8. doi:10.1124/jpet.105.090498. PMID 16020629.